Sarepta Therapeutics, Inc. (SRPT)
USD 54.87
(-6.39%)
USD 54.87
(-6.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 968.37 Million USD | 48.85% |
| 2022 | 650.58 Million USD | 166.56% |
| 2021 | -977.48 Million USD | -127.43% |
| 2020 | -429.78 Million USD | -307.54% |
| 2019 | -105.46 Million USD | -312.09% |
| 2018 | 49.72 Million USD | 129.49% |
| 2017 | -168.64 Million USD | -58.69% |
| 2016 | -106.27 Million USD | -86.75% |
| 2015 | -56.9 Million USD | 15.35% |
| 2014 | -67.22 Million USD | 73.67% |
| 2013 | -255.29 Million USD | -37.33% |
| 2012 | -185.9 Million USD | -388.42% |
| 2011 | -38.06 Million USD | -20.2% |
| 2010 | -31.66 Million USD | 31.57% |
| 2009 | -46.27 Million USD | -407.53% |
| 2008 | -9.11 Million USD | 59.76% |
| 2007 | -22.66 Million USD | -12.41% |
| 2006 | -20.15 Million USD | 41.73% |
| 2005 | -34.59 Million USD | -107.73% |
| 2004 | -16.65 Million USD | -32.97% |
| 2003 | -12.52 Million USD | -20.61% |
| 2002 | -10.38 Million USD | 6.18% |
| 2001 | -11.06 Million USD | 57.26% |
| 2000 | -25.89 Million USD | -197.68% |
| 1999 | -8.7 Million USD | -2.35% |
| 1998 | -8.5 Million USD | 51.7% |
| 1997 | -17.6 Million USD | -486.67% |
| 1996 | -3 Million USD | -328.57% |
| 1995 | -700 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 952.05 Million USD | -1.69% |
| 2024 Q2 | 986.29 Million USD | 3.6% |
| 2023 Q2 | 512.75 Million USD | 23.1% |
| 2023 FY | 968.37 Million USD | 48.85% |
| 2023 Q4 | 968.37 Million USD | 16.73% |
| 2023 Q1 | 416.54 Million USD | -35.97% |
| 2023 Q3 | 829.57 Million USD | 61.79% |
| 2022 Q1 | -96.41 Million USD | 90.14% |
| 2022 Q2 | 271.67 Million USD | 381.79% |
| 2022 Q3 | 539.37 Million USD | 98.54% |
| 2022 Q4 | 650.58 Million USD | 20.62% |
| 2022 FY | 650.58 Million USD | 166.56% |
| 2021 Q1 | -330.05 Million USD | 23.21% |
| 2021 FY | -977.48 Million USD | -127.43% |
| 2021 Q2 | -539 Million USD | -63.31% |
| 2021 Q3 | -440.77 Million USD | 18.22% |
| 2021 Q4 | -977.48 Million USD | -121.77% |
| 2020 Q3 | -705.93 Million USD | 19.17% |
| 2020 FY | -429.78 Million USD | -307.54% |
| 2020 Q1 | -1.01 Billion USD | -858.65% |
| 2020 Q2 | -873.4 Million USD | 13.61% |
| 2020 Q4 | -429.78 Million USD | 39.12% |
| 2019 Q3 | -238.66 Million USD | 27.09% |
| 2019 Q2 | -327.34 Million USD | -28.74% |
| 2019 Q1 | -254.27 Million USD | -611.36% |
| 2019 Q4 | -105.46 Million USD | 55.81% |
| 2019 FY | -105.46 Million USD | -312.09% |
| 2018 Q4 | 49.72 Million USD | -75.83% |
| 2018 Q2 | 29.06 Million USD | 122.99% |
| 2018 FY | 49.72 Million USD | 129.49% |
| 2018 Q3 | 205.74 Million USD | 607.9% |
| 2018 Q1 | -126.42 Million USD | 25.03% |
| 2017 Q4 | -168.64 Million USD | 71.24% |
| 2017 Q2 | -157.13 Million USD | 39.8% |
| 2017 Q3 | -586.34 Million USD | -273.16% |
| 2017 Q1 | -261.03 Million USD | -145.63% |
| 2017 FY | -168.64 Million USD | -58.69% |
| 2016 Q4 | -106.27 Million USD | 71.78% |
| 2016 Q2 | -91.6 Million USD | -438.08% |
| 2016 Q3 | -376.54 Million USD | -311.06% |
| 2016 Q1 | -17.02 Million USD | 70.08% |
| 2016 FY | -106.27 Million USD | -86.75% |
| 2015 Q4 | -56.9 Million USD | -74.92% |
| 2015 Q3 | -32.53 Million USD | 25.86% |
| 2015 Q2 | -43.87 Million USD | 35.53% |
| 2015 Q1 | -68.05 Million USD | -1.24% |
| 2015 FY | -56.9 Million USD | 15.35% |
| 2014 Q2 | -101.13 Million USD | -113.11% |
| 2014 Q4 | -67.22 Million USD | -46.06% |
| 2014 FY | -67.22 Million USD | 73.67% |
| 2014 Q1 | -47.45 Million USD | 81.41% |
| 2014 Q3 | -46.02 Million USD | 54.49% |
| 2013 Q4 | -255.29 Million USD | 6.12% |
| 2013 FY | -255.29 Million USD | -37.33% |
| 2013 Q3 | -271.95 Million USD | -76.05% |
| 2013 Q2 | -154.47 Million USD | 7.05% |
| 2013 Q1 | -166.18 Million USD | 10.61% |
| 2012 FY | -185.9 Million USD | -388.42% |
| 2012 Q1 | -28.75 Million USD | 24.46% |
| 2012 Q3 | -36.2 Million USD | -59.57% |
| 2012 Q4 | -185.9 Million USD | -413.42% |
| 2012 Q2 | -22.69 Million USD | 21.08% |
| 2011 FY | -38.06 Million USD | -20.2% |
| 2011 Q2 | -52.3 Million USD | -144.64% |
| 2011 Q3 | -44.49 Million USD | 14.93% |
| 2011 Q4 | -38.06 Million USD | 14.46% |
| 2011 Q1 | -21.38 Million USD | 32.48% |
| 2010 Q3 | -34.02 Million USD | 2.17% |
| 2010 Q4 | -31.66 Million USD | 6.93% |
| 2010 FY | -31.66 Million USD | 31.57% |
| 2010 Q1 | -38.34 Million USD | 17.13% |
| 2010 Q2 | -34.78 Million USD | 9.31% |
| 2009 Q2 | -17.42 Million USD | 21.31% |
| 2009 FY | -46.27 Million USD | -407.53% |
| 2009 Q1 | -22.13 Million USD | -142.79% |
| 2009 Q4 | -46.27 Million USD | 4.08% |
| 2009 Q3 | -48.24 Million USD | -176.93% |
| 2008 Q4 | -9.11 Million USD | 23.97% |
| 2008 Q1 | -17.83 Million USD | 21.29% |
| 2008 FY | -9.11 Million USD | 59.76% |
| 2008 Q2 | -16.4 Million USD | 8.04% |
| 2008 Q3 | -11.99 Million USD | 26.89% |
| 2007 FY | -22.66 Million USD | -12.41% |
| 2007 Q4 | -22.66 Million USD | -1231.25% |
| 2007 Q3 | -1.7 Million USD | 75.98% |
| 2007 Q1 | -14.96 Million USD | 25.77% |
| 2007 Q2 | -7.08 Million USD | 52.64% |
| 2006 Q4 | -20.15 Million USD | 21.19% |
| 2006 Q1 | -36.86 Million USD | -6.56% |
| 2006 Q3 | -25.57 Million USD | 19.48% |
| 2006 FY | -20.15 Million USD | 41.73% |
| 2006 Q2 | -31.76 Million USD | 13.84% |
| 2005 Q4 | -34.59 Million USD | -25.55% |
| 2005 Q3 | -27.55 Million USD | -0.77% |
| 2005 Q2 | -27.34 Million USD | 20.41% |
| 2005 Q1 | -34.35 Million USD | -106.29% |
| 2005 FY | -34.59 Million USD | -107.73% |
| 2004 FY | -16.65 Million USD | -32.97% |
| 2004 Q4 | -16.65 Million USD | -34.95% |
| 2004 Q3 | -12.34 Million USD | -11.74% |
| 2004 Q2 | -11.04 Million USD | -27.14% |
| 2004 Q1 | -8.68 Million USD | 30.64% |
| 2003 Q3 | -6.53 Million USD | 28.07% |
| 2003 Q2 | -9.07 Million USD | -26.59% |
| 2003 Q1 | -7.17 Million USD | 30.94% |
| 2003 FY | -12.52 Million USD | -20.61% |
| 2003 Q4 | -12.52 Million USD | -91.81% |
| 2002 FY | -10.38 Million USD | 6.18% |
| 2002 Q3 | -12.58 Million USD | 6.37% |
| 2002 Q4 | -10.38 Million USD | 17.51% |
| 2002 Q2 | -13.44 Million USD | 55.01% |
| 2002 Q1 | -29.88 Million USD | -169.98% |
| 2001 Q2 | -28.13 Million USD | -27.86% |
| 2001 Q3 | -24.61 Million USD | 12.51% |
| 2001 Q4 | -11.06 Million USD | 55.03% |
| 2001 FY | -11.06 Million USD | 57.26% |
| 2001 Q1 | -22 Million USD | 15.05% |
| 2000 Q1 | -9.58 Million USD | -10.12% |
| 2000 Q3 | -29.55 Million USD | -325.3% |
| 2000 Q4 | -25.89 Million USD | 12.37% |
| 2000 FY | -25.89 Million USD | -197.68% |
| 2000 Q2 | -6.94 Million USD | 27.46% |
| 1999 Q3 | -2.4 Million USD | 45.45% |
| 1999 FY | -8.7 Million USD | -2.35% |
| 1999 Q1 | -6.7 Million USD | 21.18% |
| 1999 Q2 | -4.4 Million USD | 34.33% |
| 1999 Q4 | -8.7 Million USD | -262.5% |
| 1998 Q4 | -8.5 Million USD | 22.02% |
| 1998 Q3 | -10.9 Million USD | 17.42% |
| 1998 Q1 | -15.8 Million USD | 10.23% |
| 1998 FY | -8.5 Million USD | 51.7% |
| 1998 Q2 | -13.2 Million USD | 16.46% |
| 1997 Q1 | -2.3 Million USD | 23.33% |
| 1997 Q4 | -17.6 Million USD | 4.86% |
| 1997 Q2 | -17.6 Million USD | -665.22% |
| 1997 Q3 | -18.5 Million USD | -5.11% |
| 1997 FY | -17.6 Million USD | -486.67% |
| 1996 Q4 | -3 Million USD | 0.0% |
| 1996 FY | -3 Million USD | -328.57% |
| 1995 FY | -700 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 1831.101% |
| Alkermes plc | -166.73 Million USD | 680.775% |
| Agenus Inc. | 274.13 Million USD | -253.247% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 48.213% |
| Aptorum Group Limited | 1.35 Million USD | -71259.261% |
| Ardelyx, Inc. | 34.51 Million USD | -2705.917% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -22525.654% |
| Bicycle Therapeutics plc | -481.46 Million USD | 301.131% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -2577.814% |
| ChromaDex Corporation | -24.04 Million USD | 4126.855% |
| Chimerix, Inc. | -25.51 Million USD | 3895.031% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -13797.351% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 4189.952% |
| CRISPR Therapeutics AG | -150.84 Million USD | 741.969% |
| Precision BioSciences, Inc. | -85.41 Million USD | 1233.799% |
| Dyadic International, Inc. | -6.37 Million USD | 15282.862% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 6177.813% |
| Fortress Biotech, Inc. | 7.66 Million USD | -12533.764% |
| Lantern Pharma Inc. | -21.7 Million USD | 4561.897% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 976.067% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 11435.105% |
| Incyte Corporation | -3.17 Billion USD | 130.499% |
| IO Biotech, Inc. | -140.69 Million USD | 788.262% |
| Jaguar Health, Inc. | 29.39 Million USD | -3194.811% |
| Novavax, Inc. | -298.29 Million USD | 424.639% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -18044.613% |
| Opthea Limited | 28.15 Million USD | -3339.154% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 5867.931% |
| ContextLogic Inc. | -232 Million USD | 517.404% |
| MiMedx Group, Inc. | -33.9 Million USD | 2956.488% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -9398.558% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 41893.989% |
| NextCure, Inc. | -6.47 Million USD | 15051.027% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 2017.542% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 15280.718% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -7861.496% |
| Vaxcyte, Inc. | -368.22 Million USD | 362.984% |
| PDS Biotechnology Corporation | -32.7 Million USD | 3060.595% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -5504.688% |
| Pharming Group N.V. | 109.8 Million USD | -781.915% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 5666.67% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 652.633% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 5328.864% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 5328.864% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 13739.127% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 16625.222% |
| Acelyrin, Inc. | -216.9 Million USD | 546.457% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 17360.818% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 56270.418% |
| Summit Therapeutics Inc. | 34.67 Million USD | -2692.807% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 14334.573% |
| Senti Biosciences, Inc. | 1.74 Million USD | -55553.908% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 624.562% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 1350.311% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 16074.563% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -970520.133% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -154100.318% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 927.348% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 675.617% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -773.436% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 12848.526% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 850.018% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -13945.46% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 499.557% |
| Immix Biopharma, Inc. | -17.5 Million USD | 5630.494% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 405.768% |
| MEI Pharma, Inc. | -3.7 Million USD | 26237.058% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -7640.213% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -498.718% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -3384.251% |
| Fortress Biotech, Inc. | 7.66 Million USD | -12533.764% |
| Precigen, Inc. | -481 Thousand USD | 201425.988% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -6777.196% |
| AlloVir, Inc. | -62.69 Million USD | 1644.66% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 1841.249% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -1470.36% |
| ImmuCell Corporation | 10.99 Million USD | -8710.996% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 728.221% |
| Onconetix, Inc. | 5.33 Million USD | -18063.546% |
| PureTech Health plc | -167.19 Million USD | 679.184% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 3279.179% |
| Elevation Oncology, Inc. | -19.11 Million USD | 5165.268% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 19826.584% |
| Seer, Inc. | -4.24 Million USD | 22939.104% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 4128.697% |
| Innoviva, Inc. | 255.56 Million USD | -278.919% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 1833.456% |
| ESSA Pharma Inc. | -33.62 Million USD | 2980.227% |
| GlycoMimetics, Inc. | -40.98 Million USD | 2462.795% |
| GT Biopharma, Inc. | -1.02 Million USD | 94946.033% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 1528.644% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -1480.845% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 822.244% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 7088.871% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 3454.039% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 1285546.146% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 3237.768% |
| Aptose Biosciences Inc. | -8.19 Million USD | 11916.899% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 31048.304% |
| Soligenix, Inc. | -4.95 Million USD | 19656.882% |
| Century Therapeutics, Inc. | 847 Thousand USD | -114230.342% |
| Kura Oncology, Inc. | -20.11 Million USD | 4913.49% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 2466.168% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 11631.055% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -53058.075% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 30390.21% |
| Autolus Therapeutics plc | -186.59 Million USD | 618.962% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 2064.096% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 451.124% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -2725.896% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -489.152% |
| GRI Bio, Inc. | -1.79 Million USD | 54078.707% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 10880.063% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 3011.802% |
| IGM Biosciences, Inc. | -72.6 Million USD | 1433.744% |
| INmune Bio, Inc. | -25.41 Million USD | 3910.861% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -541.518% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 2011.561% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 6059.48% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 33666.823% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -2447.358% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 2451.288% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -2937.096% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -156.218% |
| Verastem, Inc. | -37.27 Million USD | 2697.72% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 10773.184% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 1967.221% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 6498.269% |
| Histogen Inc. | -7.48 Million USD | 13034.126% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 4581.816% |
| Surrozen, Inc. | -32.66 Million USD | 3064.664% |
| Organovo Holdings, Inc. | -1.5 Million USD | 64358.66% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 23137.487% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -5007.423% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -36917.508% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -23200.722% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 11654.238% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 2329.128% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 6743.255% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 405.685% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 134213.232% |
| Apollomics, Inc. | -27.39 Million USD | 3634.871% |
| Amarin Corporation plc | -191.04 Million USD | 606.898% |
| Mesoblast Limited | 55.96 Million USD | -1630.39% |
| Turnstone Biologics Corp. | -14.58 Million USD | 6740.003% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 3928.792% |
| Synaptogenix, Inc. | -28.66 Million USD | 3478.672% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 103559.188% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -1887.15% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 112429.237% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 13427.379% |
| Exelixis, Inc. | -73.05 Million USD | 1425.637% |
| Better Therapeutics, Inc. | -860 Thousand USD | 112702.093% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 4132.724% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 501.199% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -131461.3% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 13119.097% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -77123.126% |
| Gritstone bio, Inc. | 39.49 Million USD | -2352.211% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 1251.446% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 36890.52% |
| Avid Bioservices, Inc. | 169.72 Million USD | -470.547% |
| Insmed Incorporated | 721.62 Million USD | -34.195% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 10693.193% |
| MediWound Ltd. | -5.32 Million USD | 18295.753% |
| OmniAb, Inc. | 9.2 Million USD | -10422.417% |
| Alector, Inc. | -35.63 Million USD | 2817.339% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -1026.401% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 19750.528% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -7214.586% |
| Zai Lab Limited | -775 Million USD | 224.952% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -184.353% |
| Aura Biosciences, Inc. | -21.52 Million USD | 4598.852% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 1274.076% |
| Immunic, Inc. | -45.34 Million USD | 2235.814% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 601.192% |
| Veracyte, Inc. | -203.82 Million USD | 575.105% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -51.714% |
| FibroGen, Inc. | 56.76 Million USD | -1605.882% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -10774.542% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 34353.623% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 46873.682% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 78.904% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 29084.675% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 683.487% |
| TG Therapeutics, Inc. | 17.86 Million USD | -5321.442% |
| Galecto, Inc. | -21.21 Million USD | 4664.376% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 4171.381% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 38.296% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 4057.086% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 8515.556% |
| XBiotech Inc. | -200.02 Million USD | 584.133% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 1251.446% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -21286.44% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 2846.159% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 1354.083% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -16915.955% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 668.247% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 1148.323% |
| Vaxxinity, Inc. | 10.13 Million USD | -9457.619% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | -31.526% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 9093.484% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 1568.218% |
| NexImmune, Inc. | -3.13 Million USD | 31002.627% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 28147.197% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 6508.24% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 3673.351% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 10888.461% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 777445.374% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 2486.814% |
| Ainos, Inc. | 4.07 Million USD | -23646.815% |
| Pluri Inc. | 22.82 Million USD | -4141.877% |
| Prothena Corporation plc | -608.34 Million USD | 259.182% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 915.435% |
| Celularity Inc. | 65.19 Million USD | -1385.47% |
| Rallybio Corporation | -24.1 Million USD | 4117.833% |
| Cue Biopharma, Inc. | -33.81 Million USD | 2963.414% |
| MeiraGTx Holdings plc | -40.3 Million USD | 2502.804% |
| Omeros Corporation | 331.17 Million USD | -192.406% |
| Humacyte, Inc. | -22.48 Million USD | 4406.582% |
| Immunocore Holdings plc | -358.59 Million USD | 370.049% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 4040.501% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 3233.808% |
| Blueprint Medicines Corporation | 702.83 Million USD | -37.782% |
| CalciMedica, Inc. | -5.53 Million USD | 17611.356% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 614.493% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 9580.889% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 2518.708% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 3012.152% |
| Pulmatrix, Inc. | -10.41 Million USD | 9396.131% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 16301.74% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 2638.876% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 969.264% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 1715.471% |
| Cytokinetics, Incorporated | 642.37 Million USD | -50.75% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 16730.225% |
| Nutriband Inc. | -251.65 Thousand USD | 384900.741% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 2938.237% |
| Vor Biopharma Inc. | 4.3 Million USD | -22420.419% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 116.043% |
| Evogene Ltd. | -19.63 Million USD | 5032.148% |
| ProKidney Corp. | -56.23 Million USD | 1821.989% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 2089.6% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 10583.473% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 28.999% |
| CorMedix Inc. | -43.05 Million USD | 2349.295% |
| BioLineRx Ltd. | 7.33 Million USD | -13100.354% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 3625.862% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -1998.464% |
| Atai Life Sciences N.V. | -28.55 Million USD | 3490.917% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -43314.724% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 4344.293% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -5360.265% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 1389.898% |
| MediciNova, Inc. | -50.78 Million USD | 2006.875% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 1328.828% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 4304958.858% |
| GeoVax Labs, Inc. | -6.45 Million USD | 15107.588% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 584.623% |
| Biomea Fusion, Inc. | -166.57 Million USD | 681.364% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 641.069% |
| Mereo BioPharma Group plc | -51.46 Million USD | 1981.478% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 1121.022% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 429.65% |
| Absci Corporation | -72.59 Million USD | 1433.891% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -21108.454% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 513.065% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 1127.882% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 1111.932% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 2578.381% |
| Allakos Inc. | -24.97 Million USD | 3977.389% |
| Imunon, Inc. | -4.21 Million USD | 23080.826% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 6668.837% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 815.198% |
| BioAtla, Inc. | -109.01 Million USD | 988.331% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -131461.3% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 103228.647% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -7992.746% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 4667.174% |
| XOMA Corporation | -29 Million USD | 3439.234% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 5947.693% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 10840.661% |
| aTyr Pharma, Inc. | -7.44 Million USD | 13100.107% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 876.965% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 565.2% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 1284.14% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 1143.927% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 112809.036% |
| Akari Therapeutics, Plc | -3.84 Million USD | 25285.384% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -59569.971% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 29.872% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 81604.038% |
| UroGen Pharma Ltd. | 4.39 Million USD | -21953.701% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -753.339% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -1345579.664% |
| Orgenesis Inc. | 21.78 Million USD | -4345.364% |
| Entera Bio Ltd. | -10.62 Million USD | 9210.716% |
| GH Research PLC | -78.07 Million USD | 1340.286% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 4444.84% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 3732.462% |
| Xencor, Inc. | 29.64 Million USD | -3166.691% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 49260.935% |
| Replimune Group, Inc. | 1.41 Million USD | -68482.011% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 395504.805% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 866.019% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 81604.038% |
| Portage Biotech Inc. | -4.98 Million USD | 19541.437% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 4304958.858% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 1564.532% |
| OncoCyte Corporation | -6.56 Million USD | 14855.112% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -107807.73% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 21356.67% |
| Purple Biotech Ltd. | -14.13 Million USD | 6949.47% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 4176.351% |
| scPharmaceuticals Inc. | -6.54 Million USD | 14895.691% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 5901.392% |
| HilleVax, Inc. | -165.48 Million USD | 685.176% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 38255.162% |
| Tharimmune, Inc. | -10.93 Million USD | 8955.481% |
| Genprex, Inc. | -6.73 Million USD | 14472.682% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 362.57% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 1194.707% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 69220.485% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 29294.868% |
| OKYO Pharma Limited | -826.84 Thousand USD | 117216.81% |
| Savara Inc. | 153 Thousand USD | -632826.797% |
| Curis, Inc. | -23.88 Million USD | 4153.996% |
| Daré Bioscience, Inc. | -5.15 Million USD | 18874.616% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 124889.05% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 15698.872% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -81619.662% |
| BeiGene, Ltd. | -2.25 Billion USD | 142.98% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -7748.426% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 259.219% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 621.795% |
| Erasca, Inc. | -37.21 Million USD | 2702.048% |
| bluebird bio, Inc. | 108.57 Million USD | -791.931% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 75290.874% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -155.679% |
| DBV Technologies S.A. | -126.98 Million USD | 862.586% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 75290.874% |
| Moderna, Inc. | -2.9 Billion USD | 133.312% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 9454.502% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 9010.361% |
| Molecular Templates, Inc. | 707 Thousand USD | -136870.014% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 3186.857% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -179.387% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 1280.057% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 1155.683% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 3100.676% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 2917.018% |
| MacroGenics, Inc. | -66.98 Million USD | 1545.664% |
| RenovoRx, Inc. | -1.17 Million USD | 82655.669% |
| Adicet Bio, Inc. | -138.78 Million USD | 797.744% |
| Prime Medicine, Inc. | -27.94 Million USD | 3565.796% |
| Aditxt, Inc. | 18.12 Million USD | -5243.988% |
| Adagene Inc. | -87.62 Million USD | 1205.109% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 23347.983% |
| Quantum-Si incorporated | -118.55 Million USD | 916.804% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -2589.565% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 13056.297% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 2096.285% |
| SciSparc Ltd. | -2.06 Million USD | 46994.818% |
| Vericel Corporation | 1.27 Million USD | -75732.263% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 8175.401% |
| Minerva Neurosciences, Inc. | 41 Million USD | -2261.653% |
| Generation Bio Co. | 31.44 Million USD | -2979.299% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 652.21% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 3231.578% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -730.563% |
| Invivyd, Inc. | -198.47 Million USD | 587.907% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 1172.757% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 40487.986% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 1467.959% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 14288.689% |
| 2seventy bio, Inc. | 181.71 Million USD | -432.91% |
| ADMA Biologics, Inc. | 90.06 Million USD | -975.187% |
| Clene Inc. | 3.34 Million USD | -28893.353% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 10761.782% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 4601.78% |
| GeoVax Labs, Inc. | -6.45 Million USD | 15107.588% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 381.404% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 3824.576% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -445.055% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 23767.656% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -19259.816% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 18690.478% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 843.168% |
| Evaxion Biotech A/S | 5.28 Million USD | -18216.75% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 960.26% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 837.683% |
| Trevena, Inc. | 2.25 Million USD | -42786.537% |
| Surrozen, Inc. | -32.66 Million USD | 3064.664% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 1979.981% |
| Cingulate Inc. | 3.08 Million USD | -31313.48% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 33071.672% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -13374.023% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 10522.499% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 1320.804% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 836.678% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 1017.529% |
| Clearmind Medicine Inc. | -3.94 Million USD | 24661.683% |
| Kronos Bio, Inc. | -36.05 Million USD | 2785.91% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -10192.04% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -66312.459% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 1884.831% |
| Statera Biopharma, Inc. | 14.41 Million USD | -6617.194% |
| ImmunityBio, Inc. | 618.22 Million USD | -56.639% |
| Korro Bio, Inc. | -132.94 Million USD | 828.416% |
| Kineta, Inc. | -4.54 Million USD | 21425.215% |
| BioVie Inc. | -17.73 Million USD | 5561.081% |
| Codexis, Inc. | -43.27 Million USD | 2337.938% |
| Celularity Inc. | 65.19 Million USD | -1385.47% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 30657.842% |
| Celcuity Inc. | 6.78 Million USD | -14175.473% |
| Virax Biolabs Group Limited | -3.36 Million USD | 28878.428% |
| Cibus, Inc. | -8.07 Million USD | 12087.844% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 22998.51% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -21089.891% |
| IN8bio, Inc. | -16.38 Million USD | 6008.707% |
| Kodiak Sciences Inc. | -103.87 Million USD | 1032.253% |
| Annexon, Inc. | -193.75 Million USD | 599.795% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -2689838.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 5633.905% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 27665.557% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 8.147% |
| Eyenovia, Inc. | 1.25 Million USD | -76834.652% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -3499.249% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 29960.561% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 3012.678% |
| Arcellx, Inc. | -296.95 Million USD | 426.099% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 5064.513% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 1744.803% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 4772.061% |
| Moolec Science SA | 117.61 Thousand USD | -823238.661% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 2621.883% |
| Geron Corporation | 14.76 Million USD | -6460.382% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 2653.874% |
| Royalty Pharma plc | 5.65 Billion USD | 82.886% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 784.748% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 13954.904% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 18157.122% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 788.106% |
| Humacyte, Inc. | -22.48 Million USD | 4406.582% |
| Structure Therapeutics Inc. | -124.33 Million USD | 878.821% |
| 89bio, Inc. | -289.05 Million USD | 435.017% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 3936.376% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 54411.722% |
| Genelux Corporation | -6.89 Million USD | 14136.498% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 3217.866% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -1058.361% |
| Notable Labs, Ltd. | -9.77 Million USD | 10005.667% |
| Liquidia Corporation | -80.17 Million USD | 1307.815% |
| Mustang Bio, Inc. | -3.73 Million USD | 26020.182% |
| Immunovant, Inc. | -635.22 Million USD | 252.446% |
| Quantum-Si incorporated | -118.55 Million USD | 916.804% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 5613.425% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 23473.835% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -11964.009% |
| Acasti Pharma Inc. | -23 Million USD | 4309.424% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 28858.899% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 6059.48% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 803.048% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 31173.989% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 4455.784% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 5315.025% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 672.064% |
| PepGen Inc. | -60.67 Million USD | 1696.14% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 4314.737% |
| United Therapeutics Corporation | -507.7 Million USD | 290.738% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 5163.15% |
| Solid Biosciences Inc. | -47.75 Million USD | 2128.017% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 112429.237% |
| Immuneering Corporation | -54.94 Million USD | 1862.518% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 23137.487% |
| Silo Pharma, Inc. | -3.52 Million USD | 27577.11% |
| Belite Bio, Inc | -87.27 Million USD | 1209.622% |
| XOMA Corporation | -29 Million USD | 3439.234% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 1469.758% |
| Bionomics Limited | 227 Million USD | -326.58% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 932.784% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 38330.478% |
| uniQure N.V. | -102.95 Million USD | 1040.62% |
| Cassava Sciences, Inc. | -121.13 Million USD | 899.414% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 23347.983% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -2264.724% |
| Forte Biosciences, Inc. | -11.96 Million USD | 8196.129% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 31396.555% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -913464.151% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 29960.561% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -10774.542% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 13157.956% |
| Altimmune, Inc. | -134.48 Million USD | 820.053% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -388.919% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 38330.478% |
| Compugen Ltd. | -12.9 Million USD | 7604.479% |
| Peak Bio, Inc. | 10.34 Million USD | -9265.215% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 342283.039% |
| Benitec Biopharma Inc. | -50.58 Million USD | 2014.472% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 1028.116% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -4829.387% |
| Zura Bio Limited | -99.8 Million USD | 1070.26% |
| PolyPid Ltd. | 6.17 Million USD | -15594.943% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -1206.5% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -4829.387% |
| Instil Bio, Inc. | 75.35 Million USD | -1185.037% |
| argenx SE | -2.02 Billion USD | 147.731% |
| Immunome, Inc. | -97.02 Million USD | 1098.029% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 4404.859% |
| Verona Pharma plc | -220.44 Million USD | 539.287% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 1449.787% |
| Shattuck Labs, Inc. | -121.42 Million USD | 897.518% |
| CervoMed Inc. | -7.79 Million USD | 12526.5% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 622.039% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 22244.477% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 835.068% |
| Moolec Science SA | 117.61 Thousand USD | -823238.661% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 42424.639% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -5991.048% |
| AnaptysBio, Inc. | -18.15 Million USD | 5435.122% |
| Design Therapeutics, Inc. | -18.15 Million USD | 5435.416% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 1475.908% |
| NeurAxis, Inc. | 145.7 Thousand USD | -664538.298% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -8521.599% |
| Lumos Pharma, Inc. | -28.49 Million USD | 3498.652% |
| Achilles Therapeutics plc | -126.92 Million USD | 862.959% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 1449.787% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 147779.38% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 4761.53% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -66312.459% |
| Nutriband Inc. | -251.65 Thousand USD | 384900.741% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 7452.35% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 13115.833% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -184.652% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -3979.958% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 316.411% |
| Palisade Bio, Inc. | -12.06 Million USD | 8127.671% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 790.165% |
| Beam Therapeutics Inc. | -262.72 Million USD | 468.594% |
| Neurogene Inc. | -131.95 Million USD | 833.87% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -4338.843% |
| AEON Biopharma, Inc. | -4.88 Million USD | 19943.811% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 356.734% |
| Sesen Bio, Inc. | -112.55 Million USD | 960.375% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 1069.736% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 41346.311% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 2581.366% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 1262.77% |
| Athira Pharma, Inc. | -88.99 Million USD | 1188.077% |
| Vaccinex, Inc. | -1.28 Million USD | 75284.627% |
| HCW Biologics Inc. | 2.85 Million USD | -33798.769% |
| XOMA Corporation | -29 Million USD | 3439.234% |
| Nektar Therapeutics | 210.24 Million USD | -360.606% |
| Arvinas, Inc. | -313.8 Million USD | 408.597% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -59569.971% |
| Merus N.V. | -192.88 Million USD | 602.052% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -1514.367% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 14057.596% |
| Rezolute, Inc. | -68.16 Million USD | 1520.576% |
| Clene Inc. | 3.34 Million USD | -28893.353% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 7443.429% |
| BeyondSpring Inc. | -13.75 Million USD | 7140.189% |
| Synlogic, Inc. | -6.68 Million USD | 14585.834% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -85294.885% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 11553.318% |
| Peak Bio, Inc. | 10.34 Million USD | -9265.215% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 1274.931% |
| Krystal Biotech, Inc. | -350.23 Million USD | 376.495% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -680.164% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 673.018% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 30772.595% |
| MannKind Corporation | 143.89 Million USD | -572.957% |
| Ikena Oncology, Inc. | -109.15 Million USD | 987.151% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 12890.622% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 3025.613% |
| Gossamer Bio, Inc. | 180.35 Million USD | -436.929% |
| CohBar, Inc. | -5.93 Million USD | 16428.139% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 3355.271% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -21108.454% |
| Legend Biotech Corporation | -949.39 Million USD | 201.999% |
| Mural Oncology plc | -255.84 Million USD | 478.505% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -2905.985% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 20657.24% |
| Disc Medicine, Inc. | -358.28 Million USD | 370.284% |
| Champions Oncology, Inc. | 4.81 Million USD | -20024.231% |
| REGENXBIO Inc. | 54.76 Million USD | -1668.146% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 360216.323% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 741.208% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 10845.421% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 1300.226% |
| Vaxart, Inc. | -8.24 Million USD | 11850.734% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 2029.81% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 861.509% |
| Cellectis S.A. | -43.85 Million USD | 2308.136% |
| Longeveron Inc. | -2.9 Million USD | 33400.481% |
| Repare Therapeutics Inc. | -107.85 Million USD | 997.827% |
| Inozyme Pharma, Inc. | 12 Million USD | -7967.128% |
| Revolution Medicines, Inc. | -608.2 Million USD | 259.219% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 78829.919% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 465.264% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 745.276% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 6288.905% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 130961.892% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 110.125% |
| Denali Therapeutics Inc. | -74.86 Million USD | 1393.499% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 8175.401% |
| Veru Inc. | 4.77 Million USD | -20159.085% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 8710.866% |
| Cingulate Inc. | 3.08 Million USD | -31313.48% |
| Passage Bio, Inc. | 4.58 Million USD | -21020.567% |
| Context Therapeutics Inc. | -14.44 Million USD | 6801.658% |
| Exicure, Inc. | 5.84 Million USD | -16456.3% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 520.347% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 2547.253% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -6071.551% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 1746.313% |
| Nuvalent, Inc. | -335.38 Million USD | 388.735% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -55735.502% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 1400.15% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 10992.891% |
| OmniAb, Inc. | 9.2 Million USD | -10422.417% |
| Anew Medical, Inc. | 1.43 Million USD | -67502.21% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -5811.32% |
| Lipocine Inc. | -4.75 Million USD | 20467.216% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 981.722% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -6257.941% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 2011.561% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -3790.318% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 14508.243% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 1571.095% |
| Ocugen, Inc. | -32.52 Million USD | 3077.701% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 1231.613% |
| Q32 Bio Inc. | -37.94 Million USD | 2651.855% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 154300.318% |
| Alumis Inc. Common Stock | -13.52 Million USD | 7257.794% |
| Equillium, Inc. | -22.39 Million USD | 4424.661% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 3887.461% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 3068.048% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 390708.878% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -622.444% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -30180.738% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -294740.778% |
| Dominari Holdings Inc. | 195 Thousand USD | -496504.103% |
| Edesa Biotech, Inc. | -5.26 Million USD | 18486.075% |
| vTv Therapeutics Inc. | -8.91 Million USD | 10959.908% |
| Bio-Techne Corporation | 267.74 Million USD | -261.677% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 6074.323% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 920.006% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 11624.194% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 7754.557% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 495.064% |
| Nkarta, Inc. | 57.29 Million USD | -1590.043% |
| BioCardia, Inc. | 212 Thousand USD | -456682.075% |
| Iterum Therapeutics plc | 13.43 Million USD | -7106.266% |